Skip to content

Evaluation of Neopterin Levels in Pre and Post-menopausal Women With Periodontitis Following Non Surgical Therapy

Biochemical Evaluation of Plasma,Urine and Salivary Neopterin Levels in Pre and Post-menopausal Women With Periodontitis Following Non-surgical Therapy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02357745
Acronym
ENLPPMNS
Enrollment
30
Registered
2015-02-06
Start date
2015-02-28
Completion date
2015-05-31
Last updated
2015-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Keywords

neopterin, plasma, urine, saliva, menopause, periodontitis

Brief summary

Neopterin has been identified as a marker of cellular immune system activation. It is synthesized by macrophages upon stimulation with the cytokine interferon-gamma and is indicative of a pro-inflammatory immune status. Neopterin concentration increases with increasing severity of periodontal disease in diverse body fluids like Urine, Saliva and Plasma. Hence Neopterin can be considered as an important inflammatory marker in periodontal disease as well as other systemic diseases.

Detailed description

At baseline - plasma, urine and saliva samples were collected and analysed for neopterin levels from the pre and post-menopausal women with periodontitis . Followed by scaling and root planing done in both the groups. After 3 months again these 3 samples were collected and analysed for post treatment neopterin levels

Interventions

PROCEDURENon surgical periodontal therapy

scaling and root planing

Sponsors

Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre
Lead SponsorOTHER

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* moderate to chronic periodontitis * non-smokers * minimum 15 natural teeth present

Exclusion criteria

* patients on long term steroid medication * with gross oral pathology or tumors * undergoing hormone replacement therapy * not undergone periodontal therapy in past 6 months * under medication in past 6 months * systemic disorders and drugs which influence the periodontium

Design outcomes

Primary

MeasureTime frame
Co-relating neopterin and periodontitis levels in pre and post menopausal women3 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026